華虹公司(688347.SH):無錫一期目前產能達9.45萬片/月
格隆匯8月15日丨華虹公司(688347.SH)披露投資者關係活動記錄表顯示,無錫一期目前產能達9.45萬片/月,幾乎所有的工藝平台都已穩步進行規模化生產。無錫二期在經過一年左右的建設後目前已完成80%左右的工程,首台設備的移入會在8月底進行,生產線至年底可完成通線,明年一季度開始釋放產能。目前所有五大工藝平台均已具備在新12英寸產線上量產的準備,例如40nm及55nm新一代IC工藝以及新一代功率器件等,我們與客户都保持一個非常高效、流暢的溝通,預計會有良好的產品交付。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.